Bill of Health

NOVEMBER 17, 2022

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016. Reforming the World Health Organization’s Essential Medicines List: Essential but Unaffordable. Limitations on the Capability of the FDA to Advise. JAMA Intern Med. 2022 Oct 3:e224226. Epub ahead of print.

FDA 189

FDA World Health Medicaid Medicaid 189

HIT Consultant

SEPTEMBER 2, 2022

Femtech a term coined by Danish entrepreneur Ida Tin in 2016 has become a revolutionary moment for women across the globe. Femtech as the term suggests focuses on using technology to solve health issues in females. World Health Organization states that 48 million couples face infertility problems.

FDA 98

FDA World Health Nurses Governance 98

SQA

JUNE 3, 2024

Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules. Last year, the World Health Organization (WHO) issued an alert about cough syrups being contaminated with diethylene glycol and ethylene glycol, which are toxic to humans and can prove fatal.

FDA 40

FDA COVID-19 Licensing Nurses 40

Bill of Health

OCTOBER 31, 2024

Food and Drug Administration (FDA) is expected to propose new rulemaking on front-of-package labeling in 2024. The World Health Organization (WHO) has recommended FOP labeling as a cost-effective intervention to improve population-level dietary habits. Since 2009, the U.S. No standardized system exists but the U.S.

Public Health 100

Public Health FDA Governance Licensing 100

SQA

OCTOBER 18, 2022

Policymakers, regulators, and legislators should not make any decisions that impact consumers’ access to FDA-approved sunscreen UV filters until the scientific community reaches an informed consensus. United States Food and Drug Administration (FDA) – Regulations and Guidances. PDA Technical Report No.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 Compliance 40

Drug & Device Law

MAY 11, 2023

A perusal of amicus briefs drew more than a few “they should know what they are talking about here” responses to groups of food and drug law scholars (as opposed to DDL bloggers), former FDA commissioners, former FDA officials, and former DOJ officials, among others. The appellate brief from FDA bears that out well.

FDA 59

FDA COVID-19 Public Health World Health 59